Performance overview
Value at beginning of month: $95,584.27
Value at end of month: $101,388.15
Month over month change: +6.07%
Total CAGR: +2.80%
Related indices, monthly change
NASDAQ: -2.62%
IVV (iShares Core S&P 500): -0.92%
IBB (iShares NASDAQ Biotechnology Index): +4.83%
MXI (iShares Global Materials): -1.01%
VEGI (iShares MSCI Global Agriculture Producers): -2.18%
ICLN (iShares Clean Energy): -1.72%
Individual performances
Gains by several of the index’s largest companies (Genscript, Intrexon, Codexis, Horizon) brought the index to its best month yet. Amyris shares continued to fall, even as the company announced a new partnership to build a new refinery in Australia.
Changes made to index
None
Allocation as of June 30, 2017
